BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16177112)

  • 1. Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils.
    Femling JK; Nauseef WM; Weiss JP
    J Immunol; 2005 Oct; 175(7):4653-61. PubMed ID: 16177112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of D-alanylation of (lipo)teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils.
    Hunt CL; Nauseef WM; Weiss JP
    J Immunol; 2006 Apr; 176(8):4987-94. PubMed ID: 16585595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.
    Weinrauch Y; Abad C; Liang NS; Lowry SF; Weiss J
    J Clin Invest; 1998 Aug; 102(3):633-8. PubMed ID: 9691100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.
    Wright GC; Weiss J; Kim KS; Verheij H; Elsbach P
    J Clin Invest; 1990 Jun; 85(6):1925-35. PubMed ID: 2189895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
    Madsen LM; Inada M; Weiss J
    Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil response of transgenic mice expressing human group IIA phospholipase A2 in bacterial infections.
    Laine VJ; Rajamäki A; Grass DS; Nevalainen TJ
    Scand J Immunol; 2000 Oct; 52(4):362-8. PubMed ID: 11013007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by group II phospholipase A2 against Staphylococcus aureus.
    Laine VJ; Grass DS; Nevalainen TJ
    J Immunol; 1999 Jun; 162(12):7402-8. PubMed ID: 10358193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections.
    Grönroos JO; Laine VJ; Nevalainen TJ
    J Infect Dis; 2002 Jun; 185(12):1767-72. PubMed ID: 12085323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid synthesis by Staphylococcus aureus during (Sub)Lethal attack by mammalian 14-kilodalton group IIA phospholipase A2.
    Foreman-Wykert AK; Weiss J; Elsbach P
    Infect Immun; 2000 Mar; 68(3):1259-64. PubMed ID: 10678935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes.
    Weiss J; Inada M; Elsbach P; Crowl RM
    J Biol Chem; 1994 Oct; 269(42):26331-7. PubMed ID: 7929350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and role of phospholipases in host-bacteria interaction.
    Elsbach P; Weiss J; Wright G; Forst S; van den Bergh CJ; Verheij HM
    Prog Clin Biol Res; 1990; 349():1-9. PubMed ID: 2204927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.
    Dominiecki ME; Weiss J
    Infect Immun; 1999 May; 67(5):2299-305. PubMed ID: 10225887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.
    Weinrauch Y; Elsbach P; Madsen LM; Foreman A; Weiss J
    J Clin Invest; 1996 Jan; 97(1):250-7. PubMed ID: 8550843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cells.
    Wijewickrama GT; Kim JH; Kim YJ; Abraham A; Oh Y; Ananthanarayanan B; Kwatia M; Ackerman SJ; Cho W
    J Biol Chem; 2006 Apr; 281(16):10935-44. PubMed ID: 16476735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.
    Koprivnjak T; Weidenmaier C; Peschel A; Weiss JP
    Infect Immun; 2008 May; 76(5):2169-76. PubMed ID: 18347049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further Insight into the Mechanism of Human PMN Lysis following Phagocytosis of Staphylococcus aureus.
    Rungelrath V; Porter AR; Malachowa N; Freedman BA; Leung JM; Voyich JM; Otto M; Kobayashi SD; DeLeo FR
    Microbiol Spectr; 2021 Oct; 9(2):e0088821. PubMed ID: 34704790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.
    Foreman-Wykert AK; Weinrauch Y; Elsbach P; Weiss J
    J Clin Invest; 1999 Mar; 103(5):715-21. PubMed ID: 10074489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2 promotes fusion between PMN-specific granules and complex liposomes.
    Blackwood RA; Transue AT; Harsh DM; Brower RC; Zacharek SJ; Smolen JE; Hessler RJ
    J Leukoc Biol; 1996 May; 59(5):663-70. PubMed ID: 8656051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A2 and NADPH oxidase.
    Hazan I; Dana R; Granot Y; Levy R
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):867-76. PubMed ID: 9307039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the activation-related antigen CD69 on human eosinophils by type IIA phospholipase A2.
    Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
    Inflamm Res; 2000 Apr; 49(4):177-83. PubMed ID: 10858018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.